PATANJALI - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.5
| Stock Code | PATANJALI | Market Cap | 46,158 Cr. | Current Price | 424 ₹ | High / Low | 654 ₹ |
| Stock P/E | 22.9 | Book Value | 120 ₹ | Dividend Yield | 0.83 % | ROCE | 12.0 % |
| ROE | 16.5 % | Face Value | 2.00 ₹ | DMA 50 | 452 ₹ | DMA 200 | 509 ₹ |
| Chg in FII Hold | -1.62 % | Chg in DII Hold | -0.98 % | PAT Qtr | 693 Cr. | PAT Prev Qtr | 624 Cr. |
| RSI | 37.5 | MACD | -10.4 | Volume | 26,58,039 | Avg Vol 1Wk | 22,35,569 |
| Low price | 408 ₹ | High price | 654 ₹ | PEG Ratio | 0.73 | Debt to equity | 0.21 |
| 52w Index | 6.53 % | Qtr Profit Var | 93.2 % | EPS | 16.7 ₹ | Industry PE | 20.4 |
📊 Entry Price Zone: 410 ₹ – 440 ₹ (ideal accumulation range near support levels)
📈 Exit / Holding Strategy: If already holding, maintain a 3–4 year horizon with focus on ROE/ROCE improvement. Exit if price sustains below 410 ₹ or if profitability metrics weaken further.
Positive
✅ ROE (16.5%) and ROCE (12.0%) show moderate efficiency.
✅ EPS of 16.7 ₹ supports valuation strength.
✅ Dividend yield at 0.83% provides modest income support.
✅ PAT growth from 624 Cr. to 693 Cr. reflects earnings momentum.
✅ PEG ratio (0.73) indicates reasonable growth relative to valuation.
✅ RSI (37.5) suggests oversold territory, leaving scope for recovery.
Limitation
⚠️ Current P/E (22.9) is slightly above industry average (20.4), showing limited valuation comfort.
⚠️ ROCE (12.0%) remains moderate compared to sector leaders.
⚠️ MACD (-10.4) signals weak short-term momentum.
⚠️ FII holding decreased (-1.62%) and DII holding decreased (-0.98%), reflecting reduced institutional confidence.
⚠️ Price remains far below 52-week high of 654 ₹, showing long-term weakness.
Company Negative News
❌ Institutional outflows (FII -1.62%, DII -0.98%) weaken sentiment.
❌ Price underperformance with 52w index at 6.53%.
❌ Technicals show price below DMA 50 (452 ₹) and DMA 200 (509 ₹).
Company Positive News
🌟 Quarterly profit variation (+93.2%) highlights strong earnings recovery.
🌟 PAT growth quarter-on-quarter shows operational strength.
🌟 Strong trading volumes (26.6L vs avg 22.3L) indicate investor participation.
Industry
🥫 FMCG and consumer goods sector supported by rising demand and brand strength.
📊 Industry PE at 20.4 suggests PATANJALI trades at a slight premium.
📈 Long-term demand outlook favorable due to health-focused product portfolio.
Conclusion
🔎 PATANJALI demonstrates moderate fundamentals with improving profitability and reasonable PEG ratio. However, institutional outflows and weak momentum limit near-term upside. Accumulation is best in the 410 ₹ – 440 ₹ zone. For existing holders, a 3–4 year horizon is favorable, with exit only if price breaks below 410 ₹ or fundamentals deteriorate.
Would you like me to expand this into a peer benchmarking against Dabur, HUL, and Nestle, or refine it into a swing trading setup with short-term entry/exit levels?